» Articles » PMID: 26838558

Comorbidity of Adult ADHD and Its Subtypes With Substance Use Disorder in a Large Population-Based Epidemiological Study

Overview
Journal J Atten Disord
Publisher Sage Publications
Specialty Psychiatry
Date 2016 Feb 4
PMID 26838558
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study is to explore the role and possible substance preference in ADHD and subtypes in substance use disorder (SUD). Using self-report data on ADHD (4th ed.; ) symptoms and SUD (alcohol, illicit drugs, and nicotine) in 18,167 Swedish twins, aged 20 to 45 years, we obtained odds ratios (OR) from mixed effect logistic regression, controlling for age, sex, education, and nonindependence of twin data. : Increased ADHD symptoms were significantly associated with increased odds for all SUD. ORs ranged between 1.33 for regular nicotine (95% confidence interval [CI] = [1.12, 1.59]); 2.54 for multiple drug use (95% CI = [2.00, 3.23]), and 3.58 for alcohol dependence (95% CI = [2.86, 4.49]). ADHD symptoms and subtypes in the population are associated with increased risks for all SUD outcomes, with no difference between ADHD subtypes, no substance preference, and no sex differences for the comorbidity. Clinicians need to consider ADHD evaluation and treatment as part of management of SUD in adults.

Citing Articles

Exogenous ketone bodies and the ketogenic diet as a treatment option for neurodevelopmental disorders.

Omori N, Malys M, Woo G, Mansor L Front Nutr. 2025; 11:1485280.

PMID: 39749357 PMC: 11693454. DOI: 10.3389/fnut.2024.1485280.


Neural markers of error processing relate to task performance, but not to substance-related risks and problems and externalizing problems in adolescence and emerging adulthood.

Boer O, Wiker T, Bukhari S, Kjelkenes R, Timpe C, Voldsbekk I Dev Cogn Neurosci. 2024; 71():101500.

PMID: 39729859 PMC: 11732202. DOI: 10.1016/j.dcn.2024.101500.


Global screening of health behaviors: Introducing Lev-screening (Lev-s)-development and psychometric evaluation.

Sjowall D, Stalhand F, Schettini G, Gustavsson P, Hirvikoski T PLoS One. 2024; 19(12):e0315565.

PMID: 39724222 PMC: 11670939. DOI: 10.1371/journal.pone.0315565.


How depression and ADHD relate to exercise addiction: a cross-sectional study among frequent exercisers.

Baltes-Flueckiger L, Wagner A, Sattler I, Meyer M, Tschopp A, Walter M Front Psychol. 2024; 15:1427514.

PMID: 39386141 PMC: 11461187. DOI: 10.3389/fpsyg.2024.1427514.


ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor.

Beslot A, Grall-Bronnec M, Balem M, Schreck B, Laforgue E, Victorri-Vigneau C Harm Reduct J. 2024; 21(1):165.

PMID: 39252018 PMC: 11382469. DOI: 10.1186/s12954-024-01079-7.